Your provider must evaluate baseline health status, renal function, cardiovascular history, and medication interactions before initiating therapy
Cognitive changes : Difficulty concentrating, memory problems, or depression may indicate thyroid or metabolic issues
New research identifies a mechanism of action for the GLP-1 receptor, the target of GLP-1 diabetes drugs Research led by Imperial has uncovered a hidden cellular mechanism that explains how widely used type 2 diabetes drugs signal to protect the pancreas, opening up new possibilities for improving future diabetes therapies
Lee BY, Han JA, Im JS, Morrone A, Johung K, Goodwin EC et al
Or can they afford not to?
But, like all of the GLP-1 agonists, it is not magic